Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-11-17-Speech-1-076"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20031117.6.1-076"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"Mr President, ladies and gentlemen, yes! Yes to research. I remember the temporary committee on human genetics; yes to research and yes to the compromises reached in the sixth framework programme. And then we perhaps need to talk about something that no one has yet mentioned, even though I have been listening to the debate from the outset. There are those who are here to criticise this research and reject it because of something that has remained unsaid and that I am going to say out loud now. It is almost a vulgarity; it is the word ‘abortion’. There are some here who are refusing to support this research in a bid to fight against abortion. It is all very well to talk about suffering, Parkinson’s disease and so on, but I would also like to talk about this issue, because it concerns women’s rights. There are two aspects to this. Firstly, research on stem cells is not an ethical battle over whether or not there is a right to abortion in European countries. Secondly, however, men and women are not on an equal footing where embryonic stem cells are concerned. I would be glad if someone other than myself were to say this in this House. There are a whole series of amendments, Commissioner, that seek to ensure that this is not a source of financial gain, and that you reject it on the basis of Article 152 on the grounds that this is not within the competence of the European Union and our institutions. In fact, I might remind you that Article 3 of the Charter of Fundamental Rights provides that the human body cannot be a source of financial gain, and I would also remind you that this charter will – as, I hope, all of us here wish – be incorporated in the constitution very soon. Moreover, I would draw your attention to the fact that, even though embryonic stem cells do after all affect first and foremost women, and what women carry within them, there is no question of their becoming research instruments, economically speaking. This is not to be a source of financial gain. Even though we might think that it is not up to us to say it, I nevertheless believe that we should confront this fundamental and historically significant issue."@en1

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph